These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26935744)

  • 1. Knockdown of SALL4 inhibits the proliferation and reverses the resistance of MCF-7/ADR cells to doxorubicin hydrochloride.
    Chen YY; Li ZZ; Ye YY; Xu F; Niu RJ; Zhang HC; Zhang YJ; Liu YB; Han BS
    BMC Mol Biol; 2016 Mar; 17():6. PubMed ID: 26935744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced expression of AMOT reverses adriamycin resistance in breast cancer cells.
    Zhang H; Wang Y; Gao Y; Du M; Pan E; Sun M; Zhang X
    Cell Biol Int; 2024 Sep; 48(9):1301-1312. PubMed ID: 39021301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aconitine linoleate, a natural lipo-diterpenoid alkaloid, stimulates anti-proliferative activity reversing doxorubicin resistance in MCF-7/ADR breast cancer cells as a selective topoisomerase IIα inhibitor.
    Luan S; Gao Y; Liang X; Zhang L; Wu Q; Hu Y; Yin L; He C; Liu S
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jan; 395(1):65-76. PubMed ID: 34727218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Therapeutic Effect of Natural Killer Cells on Doxorubicin-Resistant Breast Cancer Cells In Vitro.
    Hwang MH; Li XJ; Kim JE; Jeong SY; Lee SW; Lee J; Ahn BC
    PLoS One; 2015; 10(8):e0136209. PubMed ID: 26295571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Modification of Metadherin/MTDH Impacts the Sensitivity of Breast Cancer to Doxorubicin.
    Song Z; Wang Y; Li C; Zhang D; Wang X
    PLoS One; 2015; 10(5):e0127599. PubMed ID: 25993398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of UbcH10 enhances the chemosensitivity of dual drug resistant breast cancer cells to epirubicin and docetaxel.
    Wang C; Pan YH; Shan M; Xu M; Bao JL; Zhao LM
    Int J Mol Sci; 2015 Mar; 16(3):4698-712. PubMed ID: 25739083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.
    Tan JL; Li F; Yeo JZ; Yong KJ; Bassal MA; Ng GH; Lee MY; Leong CY; Tan HK; Wu CS; Liu BH; Chan TH; Tan ZH; Chan YS; Wang S; Lim ZH; Toh TB; Hooi L; Low KN; Ma S; Kong NR; Stein AJ; Wu Y; Thangavelu MT; Suzuki A; Periyasamy G; Asara JM; Dan YY; Bonney GK; Chow EK; Lu GD; Ng HH; Kanagasundaram Y; Ng SB; Tam WL; Tenen DG; Chai L
    Gastroenterology; 2019 Dec; 157(6):1615-1629.e17. PubMed ID: 31446059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting SALL4 by entinostat in lung cancer.
    Yong KJ; Li A; Ou WB; Hong CK; Zhao W; Wang F; Tatetsu H; Yan B; Qi L; Fletcher JA; Yang H; Soo R; Tenen DG; Chai L
    Oncotarget; 2016 Nov; 7(46):75425-75440. PubMed ID: 27705911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SiRNA-Mediated Knockdown of ABCB1 Enhances the Efficacy of Doxorubicin and Vinorelbine in Breast Cancer Cells.
    Abbasfard Z; Behzad-Behbahani A; Rastegari B; Naeimi S; Moghanibashi M; Safari F
    Curr Pharm Biotechnol; 2024 Apr; ():. PubMed ID: 38616741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer.
    Wang Y; Liu Y; Du X; Ma H; Yao J
    Onco Targets Ther; 2020; 13():1909-1919. PubMed ID: 32184626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT7 interacts with TEK (TIE2) to promote adriamycin induced metastasis in breast cancer.
    Yang F; Hu Y; Shao L; Zhuang J; Huo Q; He S; Chen S; Wang J; Xie N
    Cell Oncol (Dordr); 2021 Dec; 44(6):1405-1424. PubMed ID: 34797559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between ferroptosis and adriamycin resistance in breast cancer regulated by transferrin receptor and its molecular mechanism.
    Yu X; Cheng L; Liu S; Wang M; Zhang H; Wang X; Zhang H; Yang Z; Wu S
    FASEB J; 2024 Mar; 38(5):e23550. PubMed ID: 38466338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new advance of SALL4 in cancer: Function, regulation, and implication.
    Abouelnazar FA; Zhang X; Wang M; Zhang J; Yu D; Zang X; Zhang J; Li Y; Xu J; Yang Q; Zhou Y; Tang H; Wang Y; Gu J; Zhang X
    J Clin Lab Anal; 2023 May; 37(9-10):e24927. PubMed ID: 37337914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-sanguinarine nanoparticles: formulation and evaluation of breast cancer cell apoptosis and cell cycle.
    El-Readi MZ; Abdulkarim MA; Abdellatif AAH; Elzubeir ME; Refaat B; Althubiti M; Almaimani RA; Mukhtar MH; Al-Moraya IS; Eid SY
    Drug Dev Ind Pharm; 2024 Jan; ():1-15. PubMed ID: 38180322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Static Magnetic Field Remotely Boosts the Efficiency of Doxorubicin through Modulating ROS Behaviors.
    Hajipour Verdom B; Abdolmaleki P; Behmanesh M
    Sci Rep; 2018 Jan; 8(1):990. PubMed ID: 29343746
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Ghasemi M; Reiazi N; Behzad-Behbahani A; Takhshid MA
    Avicenna J Med Biotechnol; 2024; 16(1):34-39. PubMed ID: 38605743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Modeling of Drug Response in Non-Hodgkin's Lymphoma.
    Frieboes HB; Smith BR; Wang Z; Kotsuma M; Ito K; Day A; Cahill B; Flinders C; Mumenthaler SM; Mallick P; Simbawa E; Al-Fhaid AS; Mahmoud SR; Gambhir SS; Cristini V
    PLoS One; 2015; 10(6):e0129433. PubMed ID: 26061425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-state model of chemoresistance to characterize phenotypic dynamics in breast cancer.
    Howard GR; Johnson KE; Rodriguez Ayala A; Yankeelov TE; Brock A
    Sci Rep; 2018 Aug; 8(1):12058. PubMed ID: 30104569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titanium dioxide nanostructure-loaded Adriamycin surmounts resistance in breast cancer therapy: ABCA/P53/C-myc crosstalk.
    Abdel-Megeed RM; Abdel-Hamid AZ; Kadry MO
    Future Sci OA; 2024; 10(1):FSO979. PubMed ID: 38827789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum to "Essential oils from Inula japonica and Angelicae dahuricae enhance sensitivity of MCF-7/ADR breast cancer cells to doxorubicin via multiple mechanisms" [J. Ethnopharmacol. 180 (2016) 18-27].
    Wu M; Li T; Chen L; Peng S; Liao W; Bai R; Zhao X; Yang H; Wu C; Zeng H; Liu Y
    J Ethnopharmacol; 2024 Feb; 320():117496. PubMed ID: 38008656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.